[Form 4] Eastman Chemical Company Insider Trading Activity

Rhea-AI Filing Summary

Insider purchase reported: Eastman Chemical Co. (EMN) executive Brad A. Lich purchased 3,280 shares of Common Stock on 08/27/2025 at a reported price of $68.49 per share. After the transaction, Mr. Lich beneficially owned 83,487 shares directly, plus 2,540 shares held through a 401(k) plan and 1,223 shares held through an ESOP.

Positive

• Reported insider purchase: 3,280 shares acquired on 08/27/2025 at $68.49 per share.
• Detailed beneficial ownership disclosed: 83,487 direct shares plus 2,540 via 401(k) and 1,223 via ESOP.

Negative

• None.

Insights

Financial Analyst

TL;DR: Executive purchased 3,280 shares at $68.49, modest change to overall holdings.

The filing documents a personal purchase by Brad A. Lich on 08/27/2025 of 3,280 common shares at $68.49 each. Post-transaction holdings include 83,487 direct shares and additional indirect holdings through a 401(k) (2,540) and ESOP (1,223). The transaction is a non-derivative acquisition and is reported on Form 4 under Section 16.

Corporate Governance Expert

TL;DR: Form 4 properly discloses a routine insider purchase and aggregated beneficial ownership.

The submission includes a signed Form 4 (filed 08/28/2025 by POA) that lists relationship as EVP & CCO and records the purchase with transaction code P. It details direct and indirect ownership components, fulfilling disclosure requirements for a Section 16 officer.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LICH BRAD A

(Last) (First) (Middle)

200 S. WILCOX DRIVE

(Street)

KINGSPORT TN 37660

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EASTMAN CHEMICAL CO [ EMN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & CCO

3. Date of Earliest Transaction (Month/Day/Year)
08/27/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/27/2025		P		3,280	A	$68.49	83,487	D
Common Stock								2,540	I	By 401(k) Plan
Common Stock								1,223	I	By ESOP

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Mark D. Austin, by Power of Attorney for Brad A. Lich	08/28/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Brad A. Lich report on Form 4 for EMN?

The filing reports a purchase of 3,280 shares of Eastman Chemical Co. common stock on 08/27/2025 at $68.49 per share.

How many shares does Brad A. Lich beneficially own after the reported transaction?

After the transaction he beneficially owns 83,487 shares directly plus 2,540 via a 401(k) plan and 1,223 via an ESOP.

What is the reporting person’s role at Eastman Chemical (EMN)?

The form lists Brad A. Lich’s relationship to the issuer as EVP & CCO and as an officer (Section 16 reporting person).

When was the Form 4 signed and filed?

The signature block shows the form was signed by power of attorney on 08/28/2025.